Article
EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Jul 2009
Schmid Katharina, Oehl Natalie, Wrba Fritz, Pirker Robert, Pirker Christine, Filipits Martin
Abstract excerpt
PURPOSE: The epidermal growth factor receptor (EGFR) and its downstream factors KRAS and BRAF are mutated with different frequencies in non-small cell lung cancer and mutations predict clinical response to EGFR inhibitors. The present study compared the mutational status of EGFR, KRAS, and BRAF in primary tumors with the one in corresponding lymph node metastases. EXPERIMENTAL DESIGN: Direct bidirectional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
